细胞毒性T细胞
重编程
效应器
细胞生物学
化学
体内
CD8型
生物
细胞毒性
癌症研究
分子生物学
体外
白细胞介素21
免疫系统
T淋巴细胞
作者
Angela R. Corrigan,Shin Foong Ngiow,Maura Statzu,Amie Albertus,María Betina Pampena,Jayme M.L. Nordin,Stephen D. Carro,Justin L. Harper,Rachelle L. Stammen,Jennifer Wood,Houping Ni,Justin Su,Marziyeh Hajialyani,Vladimir V. Shuvaev,Víctor Alcalde,Mohammed-Alkhatim A. Ali,Jacob T. Hamilton,Rajesvaran Ramalingam,Vincent H. Wu,Mirko Paiardini
出处
期刊:Science immunology
[American Association for the Advancement of Science]
日期:2026-05-29
卷期号:11 (119): eaec3436-eaec3436
被引量:1
标识
DOI:10.1126/sciimmunol.aec3436
摘要
Selective in vivo reprogramming of cytotoxic effector CD8 T (T eff ) cells holds tremendous promise as a therapeutic tool but has not yet been accomplished. Here, we demonstrate that fractalkine-conjugated mRNA lipid nanoparticles (mRNA-LNPs) can specifically target and deliver mRNA to CX3CR1 + T eff cells in vitro and in vivo. In mice, fractalkine-conjugated mRNA-LNPs targeted up to 95% of blood and splenic T eff cells. In addition, delivery of IL-2–encoding mRNA and human CD62L-encoding mRNA to mouse T eff cells enabled robust exogenous IL-2 secretion and CD62L expression. In rhesus macaques, fractalkine-conjugated mRNA-LNPs targeted up to ~100% of peripheral blood T eff cells, and delivery of human CD62L-encoding mRNA enabled cell-surface human CD62L expression on peripheral blood T eff cells and detection of human CD62L + T eff cells in lymphoid tissue. Collectively, these data demonstrate the potential of natural receptor ligand-based targeting of mRNA-LNPs for rapid, efficient, and transient in vivo modification of T eff cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI